AUSTIN ROXANNE S 4

What Happened

• Roxanne S. Austin, a director of AbbVie Inc. (ABBV), received an award of 1,118 restricted stock units (RSUs) on 2026-05-08. The reported acquisition price is $0.00, so there was no cash exchanged and the immediate reported value is $0. These RSUs are grants (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-08; filing date: 2026-05-12.
• Reported price: $0.00 per RSU; total reported cash value: $0.
• Shares owned after transaction: not specified in this Form 4.
• Footnote (F1): The RSUs were awarded under AbbVie’s Amended and Restated 2013 Incentive Stock Program and will be paid one-for-one in AbbVie common stock on the earlier of the director’s separation from service, death, or a change in control.
• Filing timeliness: The Form 4 was filed four days after the transaction (on 2026-05-12). That timing is consistent with the standard Form 4 requirement to report within two business days.

Context

• RSU grants are deferred equity compensation: they do not result in immediate share ownership until the payout/vesting event noted in the plan. Such awards are routine for directors and do not by themselves indicate a buy or sell signal.